Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2 Publisher Pubmed



Khorsandi K1 ; Fekrazad S2 ; Vahdatinia F3 ; Farmany A3 ; Fekrazad R4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Photodynamic, Medical Laser Research Center, YARA Institute, ACECR, Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Dental Research Center, Dental School, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Radiation Sciences Research Center, Laser Research Center in Medical Sciences, AJA University of Medical Sciences, Tehran, Iran
  5. 5. International Network for Photo Medicine and Photo Dynamic Therapy (INPMPDT), Universal Scientific Education and Research, Tehran, Iran

Source: Expert Opinion on Drug Delivery Published:2021


Abstract

Introduction: COVID-19 disease has shocked the world by its spread and contagiousness. At this time, there is no valid vaccine and no proven drug treatment for COVID-19 patients. Current treatments are focused on Oxygenation, Cytokine Storm management, anti-inflammatory effects, and antiviral therapy. Antiviral photodynamic therapy (aPDT) is based on the reaction between a photo-sensitive agent and a light source in the presence of oxygen which can produce oxidative and free radical agents to damage the virus’ structures. Recent studies show that nanotechnology can improve aPDT’s outcome. The aim of this study was to find out the potential therapeutic effects of Nano antiviral photodynamic therapy on COVID-19. Areas covered: This review evaluates Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in SARS-CoV-2. Data were extracted from published different studies published on PUBMED, SCOPUS, and Web of Science. Expert opinion: Studies indicating that aPDT and Nano-based aPDT can be useful in viral pulmonary complications like Influenza, SARS-CoV, and MERS, but there was no direct study on SARS-Cov-2. Recent studies showed that Nano-based aPDT could relate to control of the stages of viral infections. Altogether, further investigations for the application of nanomedicine in antimicrobial photodynamic inactivation are needed for COVID-19 Management. © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
19. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
33. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
46. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
47. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
50. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)